Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Meridian Bioscience Reports Second Quarter 2015 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance
April 23, 2015 7:30 AM EDTCINCINNATI--(BUSINESS WIRE)-- Meridian Bioscience, Inc., (NASDAQ: VIVO):
GENERAL HIGHLIGHTS
Meridian Bioscience, Inc., (NASDAQ: VIVO) today:
reported record fiscal 2015 second quarter and first six months net revenues of $51.5 million and $99.6 million, respectively, increases of 3% and 5%, respectively, from the same periods of the prior fiscal year; reported second quarter operating income of $15.7 million, flat from the same period of the prior fiscal year; reported six months operating income of $28.4... More


